ALB and metabolic dysfunction-associated steatotic liver disease: Future studies using conditional, hepatocyte-specific Mettl3 KO mouse model by crossing Mettl3flox/flox mice with Alb-CreERT2 will fully address the effect of liver-intrinsic Mettl3 loss on NAFLD-HCC development.